drugset / Trial / NCT03211455
Intravenous Lidocaine in Bariatric Surgery.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Although peroperative intravenous lidocaine has been shown to be useful in early recovery after colorectal surgery, its beneficial effect on the specific population of obese patients scheduled for bariatric surgery remained unknown. Investigators hypothesized that peroperative intravenous lidocaine could decrease postoperative opioid consumption and improve postoperative recovery
Timeline
- Start
- 2017-12-01
- Primary completion
- 2019-02-01
- Completion
- 2019-05-01
Outcome
Met primary endpoint
paper difference between medians (95%CI): 1.7 (0.6-3.4) mg; p = 0.004). PMID 32564365 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 mg/kg | Intravenous |